JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 31 No. 12 2034-2036
© 1990 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sprengelmeyer, J. T.
Right arrow Articles by McDermott, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sprengelmeyer, J. T.
Right arrow Articles by McDermott, R. L.

Phosphorus-32-Colloidal Chromic Phosphate: Treatment of Choice for Malignant Pericardial Effusion

James T. Sprengelmeyer and Robert L. McDermott

Nuclear Medicine Department, Kaiser Foundation Hospital, West Los Angeles, Los Angeles, California
Medical Physics Department, Southern California Permanente Medical Group, Los Angeles, California

Correspondence: For reprints contact: James T. Sprengelmeyer, MD, Nuclear Medicine Dept., Kaiser Foundation Hospital, West Los Angeles, 6041 Cadillac Ave., Los Angeles, CA 90034.

ABSTRACT

A 68-yr-old male with agnogenic myeloid metaplasia was given phosphorus-32-colloidal chromic phosphate intrapericardially for the treatment of malignant pericardial effusion. Technetium-99m-sulfur colloid was used to verify catheter placement and to visualize distribution within the pericardium. Estimated dosimetry for this mode of therapy is presented, and it is suggested that pericardial administration of phosphorus-32-colloidal chromic phosphate is the treatment of choice for malignant pericardial effusion.




This article has been cited by other articles:


Home page
Ann OncolHome page
K. Reynen, U. Kockeritz, and R. H. Strasser
Metastases to the heart
Ann. Onc., March 1, 2004; 15(3): 375 - 381.
[Full Text] [PDF]


Home page
Eur Heart JHome page
B. Maisch, A.D. Ristic, S. Pankuweit, A. Neubauer, and R. Moll
Neoplastic pericardial effusion. Efficacy and safety of intrapericardial treatment with cisplatin
Eur. Heart J., October 2, 2002; 23(20): 1625 - 1631.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1990 by the Society of Nuclear Medicine.